[Pressor and depressor action of BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinehydrochloride) as a consequence of its  -receptor-stimulating properties].
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000814:Aniline Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003042:Cocaine / Q000494:pharmacology; D004837:Epinephrine / Q000378:metabolism / Q000494:pharmacology; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013154:Spleen / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*; D013843:Thiazines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology; D014992:Xylenes / Q000037:antagonists & inhibitors / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000814:Aniline Compounds; D013566:Sympathomimetics; D013843:Thiazines; D014992:Xylenes; D012110:Reserpine; D011433:Propranolol; D003042:Cocaine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine
-Sympathicomimetische Eigenschaften als Ursache der blutdrucksteigernden und blutdrucksenkenden Wirkung von BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinhydrochlorid.